Skip to content
← Full study record

NCT00553410 · MORE INFO

Limitations, agreements, and source contact

Letrozole in Preventing Cancer in Postmenopausal Women Who Have Received 4-6 Years of Hormone Therapy for Hormone Receptor-Positive, Lymph Node-Positive, Early-Stage Breast Cancer · Source last updated 2026-09-01

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
false
restrictive Agreement
false
point Of Contact
email
mregan@jimmy.harvard.edu
organization
International Breast Cancer Study Group (IBCSG)
phone
+1 617 632 3012
title
Meredith M. Regan
Complete source fields
certain Agreement
pi Sponsor Employee
false
restrictive Agreement
false
point Of Contact
email
mregan@jimmy.harvard.edu
organization
International Breast Cancer Study Group (IBCSG)
phone
+1 617 632 3012
title
Meredith M. Regan

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice